Dr Lal Pathlabs LtdQ2 FY23
Dr Lal Pathlabs Ltd Q2 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,647P/E: 50.9Market Cap: ₹26.9K CrSector: Healthcare Services
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
No information is provided regarding the same in the latest conference call.
Margin guidance
No information is provided regarding the same in the latest conference call.
3 more insights locked — sign up free to unlock
Fundraise plans
No information is provided regarding the same in the latest conference call.
Order book
No information is provided regarding the same in the latest conference call.
Capex plans
No information is provided regarding the same in the latest conference call.
How does Dr Lal Pathlabs Ltd rank vs peers in Healthcare Services?
Pro feature1Dr Lal Pathlabs Ltd
See full Healthcare Services sector rankings
Want more stocks like Dr Lal Pathlabs Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio